Literature DB >> 3534061

Treatment of theophylline intoxication.

M J Goldberg, G D Park, W G Berlinger.   

Abstract

The treatment of theophylline intoxication is reviewed. Efforts should be made to decrease the absorption of theophylline from the gastrointestinal tract by the oral administration of activated charcoal and sorbitol; stomach emptying procedures are recommended only in limited circumstances. Patients should receive intensive supportive care and appropriate treatment for complications of intoxication, including metabolic and cardiovascular abnormalities and seizures. Despite these treatments, morbidity (including residual neurological deficits) and mortality may occur. Therefore, efforts to actively remove theophylline from the body before complications occur should be considered in an attempt to reduce morbidity and mortality. The oral administration of multiple doses of activated charcoal (which increases theophylline clearance) is recommended for nearly all patients with theophylline intoxication. Although controversial, hemoperfusion--an efficient but invasive active removal procedure--is recommended in severely intoxicated patients who satisfy specific indications; the prophylactic administration of phenobarbital to prevent seizures should also be considered in these patients. Although these recommendations are rationally based on the extant evidence, controlled clinical trials in patients with theophylline intoxication are needed to prove their utility.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534061     DOI: 10.1016/0091-6749(86)90066-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

Review 1.  Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service.

Authors:  Christopher Bryczkowski; Ann-Jeannette Geib
Journal:  J Med Toxicol       Date:  2012-12

2.  Theophylline poisoning--a review of 64 cases.

Authors:  M J Parr; F C Anaes; A C Day; S L Kletchko; P D Crone; A P Rankin
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Simon Klimovic; Martin Scurek; Martin Pesl; Deborah Beckerova; Sarka Jelinkova; Tomas Urban; Daniil Kabanov; Zdenek Starek; Marketa Bebarova; Jan Pribyl; Vladimir Rotrekl; Kristian Brat
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.